WOMAN AND HEALTH. UNITED STATES 1980MOORE EC.1980; PUBLIC HEALTH REP.; ISSN 0033-3549; USA; DA. 1980-09; SUPPL.; 84 P.; BIBL. DISSEM.Serial Issue

SULFOXYLATE ION (HSO₂^-), THE HYBRIDE DONOR IN DITHIONITE-DEPENDENT REDUCTION OF NAD⁺ ANALOGUESBLANKENHORN G; MOORE EC.1980; J. AMER. CHEM. SOC.; USA; DA. 1980; VOL. 102; NO 3; PP. 1092-1098; BIBL. 26 REF.Article

THE COST OF COAL.DIALS GE; MOORE EC.1974; ENVIRONMENT; USA; 1974, VOL. 16, NUM. 0007, P. 18 A 37Serial Issue

SCREENING FOR ADA DEFICIENCYMOORE EC; MEUWISSEN HJ.1974; J. PEDIATR.; U.S.A.; DA. 1974; VOL. 85; NO 6; PP. 802-804; BIBL. 9REF.Article

PURIFICATION OF THIOREDOXIN FROM RAT NOVIKOFF ASCITES HEPATOMAHERRMANN EC; MOORE EC.1973; J. BIOL. CHEM.; U.S.A.; DA. 1973; VOL. 248; NO 4; PP. 1219-1223; BIBL. 37 REF.Serial Issue

THE IMMUNOCHEMICAL METHOD FOR DETERMINING THIOREDOXIN REDUCTASE IN RAT TISSUES.CHIN CHUN CHEN; MOORE EC.1977; ANAL. BIOCHEM.; U.S.A.; DA. 1977; VOL. 83; NO 2; PP. 609-614; BIBL. 10 REF.Article

EARTH EMBANKMENT DESIGN AND FOUNDATION TREATMENT ON A HIGHLY SLUTIONIZED LIMESTONE.MOORE EC; COUCH FB JR.1970; 10EME CONGR. INTERNAT. GRANDS BARRAGES.; 1970, VOL. 2, NUM. 0037, P. 337 A 350Miscellaneous

EFFECT OF THE SOLVENT-DEPENDENT CONFORMATIONAL SYSTEM OF HYDROXYUREAS ON PREDICTED VS. OBSERVED LOG P.PARKER GR; LEMKE TL; MOORE EC et al.1977; J. MEDICIN. CHEM.; U.S.A.; DA. 1977; VOL. 20; NO 9; PP. 1221-1225; BIBL. 24 REF.Article

COMPARATIVE TRIAL OF CEFTIZOXIME AND CEFAMANDOLE IN THERAPY OF BACTERIAL PNEUMONIAEBRIGHT JR; FRANSON TR; MOORE EC et al.1983; CURRENT THERAPEUTIC RESEARCH; ISSN 0011-393X; USA; DA. 1983; VOL. 33; NO 1; PP. 39-45; BIBL. 6 REF.Article

STUDIES OF N-HYDROXY-N'-AMINOGUANIDINE DERIVATIVES BY NITROGEN-15 NUCLEAR MAGNETIC RESONANCE SPECTROSCOPY AND A RIBONUCLEOTIDE REDUCTASE INHIBITORSTAI AW; LIEN EJ; MOORE EC et al.1983; JOURNAL OF MEDICINAL CHEMISTRY; ISSN 0022-2623; USA; DA. 1983; VOL. 26; NO 9; PP. 1326-1329; BIBL. DISSEM.Article

POTENTIAL ANTITUMOR AGENTS. X. SYNTHESIS AND BIOCHEMICAL PROPERTIES OF 5-N-ALKYLAMINO-, N,N-DIALKYLAMINO-, AND N-ALKYLACETAMIDO-1-FORMYLISOQUINOLINE THIOSEMICARBAZONESMOONEY PD; BOOTH BA; MOORE EC et al.1974; J. MEDICIN. CHEM.; U.S.A.; DA. 1974; VOL. 17; NO 11; PP. 1145-1150; BIBL. 22 REF.Article

COMPARATIVE STUDIES OF THE ANTINEOPLASTIC ACTIVITY OF 5-HYDROXY-2-FORMYLPYRIDINE THIOSEMICARBAZONE AND ITS SELENO-SEMICARBAZONE, GUANYLHYDRAZONE AND SEMICARBAZONE ANALOGS = RECHERCHES COMPAREES SUR L'ACTIVITE ANTITUMORALE DE L'HYDROXY-5 FORMYL-2 PYRIDINE THIOSEMICARBAZONE ET DES ANALOGUES SELENO-SEMICARBAZONE GUANYL HYDRAZONE ET SEMICARBAZONEAGRAWAL KC; BOOTH BA; MICHAUD RL et al.1974; BIOCHEM. PHARMACOL.; G.B.; DA. 1974; VOL. 23; NO 17; PP. 2421-2429; BIBL. 21REF.Article

EFFECTS OF THE FERROUS CHELATE OF 4-METHYL-5-AMINO-1-FORMYLISOQUINOLINE THIOSEMICARBAZONE (MAIQ-1) ON THE KINETICS OF REDUCTION OF CDP BY RIBONUCLEOTIDE REDUCTASE OF THE NOVIKOFF TUMORPREIDECKER PJ; AGRAWAL KC; SARTORELLI AC et al.1980; MOL. PHARMACOL.; ISSN 0026-895X; USA; DA. 1980; VOL. 18; NO 3; PP. 507-512; BIBL. 26 REF.Article

SUCCESSFUL RETRANSPLANTATION OF BONE NARROW FOLLOWING FAILURE OF INITIAL ENGRAFTMENT IN A PATIENT WITH APLASTIC ANEMIA.MEUWISSEN HJ; MOORE EC; STRAUSS HS et al.1976; J. PEDIATR.; U.S.A.; DA. 1976; VOL. 89; NO 4; PP. 588-592; BIBL. 20 REF.Article

ALPHA -(N)-HETEROCYCLIC CARBOXALDEHYDE THIOSEMICARBAZONE INHIBITORS OF RIBONUCLEOSIDE DIPHOSPHATE REDUCTASE = ALPHA -(N) CARBOXALDEHYDE HETEROCYCLIQUE THIOSEMICARBAZONES INHIBITRICES DE LA RIBONUCLEOSIDE DIPHOSPHATE REDUCTASEBOOTH BA; AGRAWAL KC; MOORE EC et al.1974; CANCER RES.; U.S.A.; DA. 1974; VOL. 34; NO 6; PP. 1308-1314; BIBL. 27 REF.Article

SEPARATION OF RIBONUCLEOTIDES AND DEOXYRIBONUCLEOTIDES ON COLUMNS OF BORATE COVALENTLY LINKED TO CELLULOSE. APPLICATION TO THE ASSAY OF RIBONUCLEOSIDE DIPHOSPHATE REDUCTASEMOORE EC; PETERSON D; LI YING YANG et al.1974; BIOCHEMISTRY; U.S.A.; DA. 1974; VOL. 13; NO 14; PP. 2904-2907; BIBL. 11REF.Article

PENETRATION OF N-(PHOSPHONACETYL)-L-ASPARTATE INTO HUMAN CENTRAL NERVOUS SYSTEM AND INTRACEREBRAL TUMORSTEWART DJ; LEAVENS M; FRIEDMAN J et al.1980; CANCER RES.; ISSN 0008-5472; USA; DA. 1980; VOL. 40; NO 9; PP. 3163-3166; BIBL. 16 REF.Article

PHASE I CLINICAL STUDY OF N-(PHOSPHONACETYL)-L-ASPARTIC ACID (PALA)VALDIVIESO M; MOORE EC; BURGESS AM et al.1980; CANCER TREATM. REP.; USA; DA. 1980; VOL. 64; NO 2-3; PP. 285-292; BIBL. 10 REF.Article